Patent directory · USPTO A61K / A61P
Patents matching “The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center”
23 pharma patents match "The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 23 pharmaceutical patents matching "The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12023348
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
granted -
US 11944644
T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof
granted -
US 11932871
Methods of culturing t cells and uses of same
granted -
US 11779565
Small organic molecules for use in the treatment of neuroinflammatory disorders
granted -
US 11714089
Combination of markers for diagnosing cancer
granted -
US 11219636
Compositions and methods for treating cancer
granted -
US 11103479
Small organic molecules for use in the treatment of neuroinflammatory disorders
granted -
US 10729815
Combined treatment for nerve injuries
granted -
US 10639350
Methods and pharmaceutical compositions for improving wound healing using CD24
granted -
US 10265412
Enzyme replacement therapy for treating lysosomal storage diseases
granted -
US 9663790
Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
granted -
US 9663569
Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases
granted -
US 9394569
Methods and kits for early detection of cancer or predisposition thereto
granted -
US 9067989
Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
granted -
US 8969292
High affinity leptins and leptin antagonists
granted -
US 8912142
Method of regulating proliferation and differentiation of keratinocyes
granted -
US 8785373
Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment
granted -
US 8741315
Methods of treating tumors in immune-privileged sites
granted -
US 8614301
Methods of treating cancer using anti CD24 antibodies
granted -
US 8597655
Recombinant fusion protein and polynucleotide construct for immunotoxin production
granted -
US 8242076
Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
granted -
US 7994306
Methods of treating cancer using siRNA molecules directed against CD24
granted -
US 7985428
Method and composition for modulation of systemic inflammatory responses syndrome (SIRS)
granted